New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 Shares
Posted by: gurufocus (IP Logged)
Date: January 22, 2013 12:06PM

SVP, CFO of Synageva BioPharma Corp (GEVA) Carsten Boess sells 9,927 shares of GEVA on 01/16/2013 at an average price of $49.12 a share.

Synageva Biopharma Corp has a market cap of $1.23 billion; its shares were traded at around $50.74 with and P/S ratio of 83.8.

CEO Recent Trades:


  • President & CEO Sanj K Patel sold 60,000 shares of GEVA stock on 12/17/2012 at the average price of 46.21. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 9.8% since.
  • President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/05/2012 at the average price of 48.92. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 3.72% since.
  • President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/03/2012 at the average price of 49.34. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.84% since.
  • President & CEO Sanj K Patel sold 70,000 shares of GEVA stock on 09/04/2012 at the average price of 49.47. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.57% since.

CFO Recent Trades:


  • SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 01/16/2013 at the average price of 49.12. The price of the stock has increased by 3.3% since.
  • SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 10/16/2012 at the average price of 50.13. The price of the stock has increased by 1.22% since.

Directors and Officers Recent Trades:


  • Director Thomas J Tisch bought 21,039 shares of GEVA stock on 01/09/2013 at the average price of 47.53. Thomas J Tisch owns at least 751,995 shares after this. The price of the stock has increased by 6.75% since.
  • Director, 10% Owner Felix Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 6.75% since.
  • Director, 10% Owner Julian Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 6.75% since.
  • SVP, Chief Medical Officer Anthony Quinn sold 5,553 shares of GEVA stock on 01/17/2013 at the average price of 50.07. Anthony Quinn owns at least 15,035 shares after this. The price of the stock has increased by 1.34% since.
  • SVP, Product Development Mark Alan Goldberg sold 4,417 shares of GEVA stock on 01/02/2013 at the average price of 47.52. The price of the stock has increased by 6.78% since.


For the complete insider trading history of GEVA, click here.


Stocks Discussed: GEVA,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial